help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on April 30, 2003, doi:10.1164/rccm.200209-1051OC

Am. J. Respir. Crit. Care Med., Volume 168, Number 1, July 2003, 85-91

A more recent version of this article appeared on July 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200209-1051OCv1
168/1/85    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tzeng, H.-P.
Right arrow Articles by Liu, S.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tzeng, H.-P.
Right arrow Articles by Liu, S.-H.

Submitted on September 17, 2002
Accepted on April 25, 2003

Beta-lapachone reduces endotoxin-induced macrophage activation and lung edema and mortality

Huei-Ping Tzeng1, Feng-Ming Ho2, Kuo-Fang Chao1, Min-Liang Kuo1, Shoei-Yn Lin-Shiau1, and Shing-Hwa Liu1*

1 Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan, 2 Nursing, Chung-Tai Institute of Health Sciences and Technology, Taichung, Taiwan

* To whom correspondence should be addressed. E-mail: shliu{at}ha.mc.ntu.edu.tw.

Beta-lapachone, a 1,2-naphthoquinone, is a novel chemotherapeutic agent. It has been shown to be capable of suppressing inducible nitric oxide synthase expression and function in rat alveolar macrophages. The authors further performed experiments to examine the molecular mechanism of beta-lapachone on lipopolysaccharide-induced responses in rat alveolar macrophages, and to evaluate its in vivo anti-inflammatory effect. A significant increase in nitrite production and inducible nitric oxide synthase expression was elicited in macrophages treated with lipopolysaccharide that was inhibited by co-incubation with beta-lapachone. Beta-lapachone could also inhibit the production of tumor necrosis factor-alpha induced by lipopolysaccharide. Lipopolysaccharide induces protein tyrosine phosphorylation and nuclear factor kappaB binding activity by gel mobility shift assay in macrophages. These events were significantly inhibited by beta-lapachone. Furthermore, beta-lapachone in vivo protected against the induction of lung edema, lung inducible nitric oxide synthase protein expression and nuclear factor kappaB activation, lethality, and increased plasma nitrite and serum tumor necrosis factor-alpha levels induced by lipopolysaccharide. These results indicate that beta-lapachone suppresses inducible nitric oxide synthase induction and tumor necrosis factor-alpha production mediated by the inhibition of protein tyrosine phosphorylation and nuclear factor kappaB activation caused by lipopolysaccharide. This results in a beneficial effect in an animal model of sepsis.


Key words: beta-lapachone; inducible nitric oxide synthase; tumor necrosis factor-alpha; nuclear factor kappaB; protein tyrosine phosphorylation




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
H.-N. Kung, M.-J. Yang, C.-F. Chang, Y.-P. Chau, and K.-S. Lu
In vitro and in vivo wound healing-promoting activities of {beta}-lapachone
Am J Physiol Cell Physiol, October 1, 2008; 295(4): C931 - C943.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Wu, W. Dong, M. Zhou, F. Zhang, C. P. Marini, T. S. Ravikumar, and P. Wang
Ghrelin Attenuates Sepsis-induced Acute Lung Injury and Mortality in Rats
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 805 - 813.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Dal-Pizzol, L. P. Di Leone, C. Ritter, M. R. Martins, A. Reinke, D. Pens Gelain, A. Zanotto-Filho, L. F. de Souza, M. Andrades, D. F. Barbeiro, et al.
Gastrin-releasing Peptide Receptor Antagonist Effects on an Animal Model of Sepsis
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C.-M. Tsang, C.-K. Wong, W.-K. Ip, and C. W.-K. Lam
Synergistic effect of SCF and TNF-{alpha} on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells
J. Leukoc. Biol., July 1, 2005; 78(1): 239 - 247.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Puneet, S. Moochhala, and M. Bhatia
Chemokines in acute respiratory distress syndrome
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L3 - L15.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 239 - 253.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society